Kang, Min-gu
Kim, Kwang-il
Ihm, Sang Hyun
Rhee, Moo-Yong
Sohn, Il Suk
Lee, Hae-Young
Park, Sungha
Jeon, Eun-Seok
Song, Jong-Min
Pyun, Wook Bum
Sung, Ki-Chul
Kim, Moo Hyun
Kim, Sang-Hyun
Kim, Seok-Yeon
Kim, Shin-Jae
Kim, Eung Ju
Shin, Jinho
Lee, Sung Yun
Chun, Kook-Jin
Jeong, Jin-Ok
Chae, Shung Chull
Yoo, Ki Dong
Choi, Young Jin
Park, Yong Hwan
Kim, Cheol-Ho http://orcid.org/0000-0002-3665-4562
Funding for this research was provided by:
Boryung Pharmaceutical Co., Ltd (200125)
Article History
Received: 25 October 2018
Accepted: 24 May 2019
First Online: 1 July 2019
Ethics approval and consent to participate
: The protocol of the study was approved by the institutional review board of each study site, where the study will take place. This study will be carried out in accordance with the protocol and principles established in the latest version of the Declaration of Helsinki. Written informed consent is obtained for all eligible participants. Participation is voluntary, and participants have the right to withdraw from the study at any time. While the trial is ongoing, relevant parties (such as investigators, the institutional review board, or trial participants) will be notified of any important protocol modifications.
: Not applicable.
: The authors declare that they have no competing interests.